SAMAREA WEBB: Open Payments
NPI 1396258422 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,863 in 94 payments from 19 companies in 2025. Trend: 2023 $1,237 · 2024 $1,466 · 2025 $1,863
Food & beverage: $1,863
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $579 |
| Lilly USA, LLC | 15 | $253 |
| ABBVIE INC. | 13 | $252 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $124 |
| PFIZER INC. | 6 | $104 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| Novo Nordisk Inc | 5 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 4 | $63 |
| Dexcom, Inc. | 2 | $52 |
Products named: FARXIGA, MOUNJARO, BREZTRI, AIRSUPRA, JARDIANCE, UBRELVY, PREVNAR 20, QULIPTA.
Industry payments across OK — which companies pay providers there.
